Ureter and Renal Pelvis Cancer
This page provides general information about ureter and renal pelvis cancer — what it involves, who it may help, how it is performed, and what to consider when planning treatment abroad. This information is for educational purposes only. Final medical advice must come from a qualified healthcare professional who has evaluated your individual case.
Overview
Ureter and renal pelvis cancer affects the upper urinary tract — the renal pelvis, the funnel-shaped area where urine collects as it leaves the kidney, and the ureter, the tube that carries urine down to the bladder. Most of these cancers are urothelial (transitional cell) cancers arising from the lining that runs through the whole urinary system.
These upper tract cancers are less common than bladder cancer but are closely related to it, which shapes both treatment and long-term follow-up. Treatment usually centres on surgery, with kidney-sparing options for selected small tumours, and may include chemotherapy. Care is led by a urology and oncology team.
This page is an educational overview only and is not medical advice. Diagnosis and treatment must be arranged with a qualified urology and oncology team, and no outcome can be guaranteed.
Who May Need This
Assessment may be needed by people who notice blood in the urine, pain in the side or flank, or symptoms of a urinary blockage. Because visible blood in the urine can be the first and only sign, it should always be investigated, even if it comes and goes.
Risk is higher with smoking, exposure to certain chemicals, long-term irritation or infection, some inherited conditions such as Lynch syndrome, and a history of bladder cancer. Only a specialist can determine whether symptoms are due to an upper tract cancer, after appropriate imaging and tests.
When It May Be Recommended
Treatment is recommended once investigations confirm an upper tract cancer. Surgery is generally recommended for tumours that can be removed, with the extent depending on the grade, size and location. Kidney-sparing treatment may be recommended for small, low-grade tumours or when it is important to preserve kidney function.
Chemotherapy may be recommended before or after surgery for higher-risk disease, influenced by kidney function. When the cancer has spread, treatment focuses on systemic therapy and symptom control. The plan depends on the tumour and the person's kidney function and health, and is decided by the multidisciplinary team.
Diagnosis and Evaluation
Evaluation typically includes urine tests (including for cancer cells) and CT urography, a specialised scan that outlines the upper urinary tract. Ureteroscopy allows direct inspection and biopsy of the renal pelvis and ureter to confirm the diagnosis and grade, and cystoscopy checks the bladder because of the link between these cancers.
Blood tests assess kidney function, which is central to planning surgery and any chemotherapy. Staging imaging checks for spread. All results are reviewed by the multidisciplinary team, and a second opinion can be valuable before deciding on treatment.
Treatment Options
The main options are radical nephroureterectomy — removal of the kidney, the whole ureter and a cuff of bladder — for many tumours, and kidney-sparing surgery, such as endoscopic laser treatment or removal of just the affected ureter segment, for small, low-grade tumours or when kidney function must be preserved.
Chemotherapy may be given before or after surgery for higher-risk disease, and instillation of medication into the upper tract is used in selected cases. For advanced disease, systemic treatments including chemotherapy and immunotherapy are used. The choice is individualised to the tumour and kidney function.
How It Is Performed
Radical nephroureterectomy is performed under general anaesthesia, increasingly using minimally invasive (laparoscopic or robotic) techniques, removing the kidney, the full ureter and a small cuff of bladder around where the ureter enters, to reduce the chance of leaving cancer behind. Nearby lymph nodes may be removed as well.
Kidney-sparing procedures use ureteroscopy with laser to treat small tumours, or surgery to remove and reconnect just the affected ureter segment. The removed tissue is examined to confirm the grade, stage and margins, which guide further treatment and the follow-up plan.
Preparation
Preparation includes completing imaging, ureteroscopy and bladder inspection, assessing kidney function, and standard pre-operative checks. Your team reviews medicines, especially blood thinners, and gives fasting instructions. Stopping smoking is particularly important because of its strong link with these cancers.
If you are travelling for treatment, bring all imaging, biopsy and kidney function results. Plan an in-country stay covering surgery and initial recovery, arrange a companion, and organise the essential ongoing urological follow-up with your home team before travelling.
Benefits and Expected Goals
The goal of surgery is to remove the cancer completely and reduce the risk of recurrence within the urinary tract, while kidney-sparing options aim to achieve this and preserve kidney function for suitable small tumours. Chemotherapy aims to lower the risk of recurrence or to control more advanced disease.
Benefits depend on the grade, stage and completeness of removal, and cannot be guaranteed. Because of the risk of new tumours elsewhere in the urinary lining, follow-up is essential even after successful treatment. Your team can explain realistic goals for your situation.
Risks and Possible Complications
Surgery and additional treatments carry risks that the team works to minimise.
- Bleeding, infection and blood clots after surgery
- Reduced overall kidney function, especially if the remaining kidney is not fully healthy
- Injury to nearby organs, and, after kidney-sparing surgery, narrowing of the ureter
- Higher risk of a later bladder or contralateral tumour, needing surveillance
- Chemotherapy side effects and the possibility of recurrence
Your team will explain the risks specific to your operation and treatment. Report heavy bleeding, inability to pass urine, fever or severe pain promptly after surgery.
Recovery, Follow-up & Aftercare
Recovery from minimally invasive nephroureterectomy usually involves a hospital stay of a few days and several weeks to regain full strength, avoiding heavy lifting for a period. Kidney-sparing procedures often allow quicker recovery. Kidney function is monitored, particularly if chemotherapy is planned.
Because new tumours can develop elsewhere in the urinary lining, long-term surveillance with bladder inspection (cystoscopy) and imaging is important. If you were treated abroad, arrange this ongoing follow-up with your home urology team and carry your operation and pathology details with you.
Medical Tourism Planning
Choose a JCI- or ISO-accredited hospital with an experienced urology service, minimally invasive and robotic capability, and access to medical oncology. Confirm the surgeon's experience with nephroureterectomy and, if relevant, kidney-sparing techniques, and the plan in writing.
Plan an in-country stay covering surgery and initial recovery, request a written treatment plan and cost estimate, and arrange the essential ongoing surveillance with your home team. Carry your pathology report and consider medical travel insurance.
Estimated Cost Factors
Cost depends on the type of surgery (open, laparoscopic, robotic or kidney-sparing), the length of hospital stay, and whether chemotherapy or other treatments are needed. Imaging, ureteroscopy, pathology, and management of any complications also affect the total.
Many destinations offer this treatment at a fraction of typical US prices, but costs vary by case and cannot be judged from online figures. Always request a personalized written quote detailing what is included before deciding.
Choosing a Hospital or Specialist
Look for a hospital with recognised accreditation, an experienced urology team, minimally invasive and robotic surgery, reliable pathology, and access to medical oncology. Confirm the surgeon's experience with upper tract cancer and the availability of the surveillance you will need afterwards.
Ask about international patient services, interpreter support, and how the essential long-term follow-up would be coordinated with your home doctors. Written treatment and cost plans are signs of a quality programme.
Alternatives
Depending on the tumour, alternatives to radical surgery include kidney-sparing endoscopic or segmental surgery for small, low-grade tumours, and chemotherapy or immunotherapy for advanced disease. Instillation of medication into the upper tract is an option in selected cases.
Each approach balances cancer control against preserving kidney function and quality of life. Clinical trials may offer newer options. Discuss all of them with your urology and oncology team so the plan fits the tumour, your kidney function and your priorities.
Questions to Ask Your Doctor
- Where is my tumour, and what is its grade and stage?
- Do you recommend removing the kidney and ureter, or a kidney-sparing approach, and why?
- How will my kidney function be affected, and can I still have chemotherapy if needed?
- Will I need chemotherapy or immunotherapy before or after surgery?
- What surveillance of my bladder and urinary tract will I need afterwards?
- What are the specific risks in my case?
- If I travel, how will long-term follow-up be arranged at home?
- What is included in the written cost estimate?
✅Safety Checklist Before Traveling
Use this checklist to help ensure your safety when planning medical treatment abroad.
- Verify hospital accreditation (JCI, ISO, TEMOS)
- Verify specialist credentials and board certification
- Get a written treatment plan from your doctor
- Get a written cost estimate with included/excluded items
- Arrange follow-up care with your local doctor
- Confirm medical visa and travel documents
- Consider medical travel insurance
- Keep copies of all medical records and reports
- Share your travel plans with a family member or companion
- Know the emergency contact numbers at your destination
🚨 When to Seek Urgent Medical Help
Contact a healthcare provider immediately if you experience any of the following:
- • Severe chest pain or difficulty breathing
- • Heavy or uncontrolled bleeding
- • Sudden weakness, confusion, or loss of consciousness
- • Severe allergic reaction (swelling, rash, difficulty breathing)
- • High fever (above 101°F / 38.3°C) after a procedure
- • Worsening pain, redness, or swelling at a surgical site
- • Any symptom that feels severe, unexpected, or concerning to you
Seek urgent care for heavy or persistent blood in the urine with clots, an inability to pass urine, severe flank pain, or fever with urinary symptoms, and after surgery for wound problems, breathlessness or leg swelling — a blocked urinary tract or significant bleeding needs prompt assessment.
🚨 If you have a life-threatening emergency, call local emergency services immediately. Do not wait.
Frequently Asked Questions
These are cancers of the upper urinary tract — the renal pelvis, where urine collects as it leaves the kidney, and the ureter, the tube carrying urine to the bladder. Most are urothelial (transitional cell) cancers of the lining, and they are collectively known as upper tract urothelial cancers. They are less common than bladder cancer.
The most common symptom is blood in the urine, which may be visible or found only on testing. Pain in the side or flank, or symptoms from a blockage of urine flow, can also occur. Because these symptoms have many causes, they should be investigated promptly by a doctor to rule out cancer.
Diagnosis usually involves urine tests, a specialised CT scan of the urinary tract (CT urography), and ureteroscopy — passing a thin camera into the ureter and renal pelvis to inspect and biopsy the tumour. The bladder is also examined by cystoscopy, because upper tract and bladder cancers are linked. Kidney function is checked to help plan treatment.
For small, low-grade tumours or when preserving kidney function is important, kidney-sparing approaches such as endoscopic laser treatment or removing only the affected segment of ureter may be possible. Many higher-grade or larger tumours are treated by removing the kidney and ureter (nephroureterectomy). The choice depends on the tumour and your kidney function.
Because the whole urinary lining shares the same risk, people treated for upper tract cancer have a higher chance of developing a tumour in the bladder or the other side later. Regular surveillance with bladder inspection and imaging is therefore essential to catch new tumours early. Your team will arrange a follow-up schedule.
References
This section lists sources supporting the information on this page. Content is periodically reviewed for accuracy.
- • National Cancer Institute (NCI) — Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ)
- • American Cancer Society — Kidney and Urinary Tract Cancers
- • European Association of Urology (EAU) — Upper Urinary Tract Urothelial Carcinoma Guidelines